Improving sensitivity and specificity of capturing and detecting targeted cancer cells with anti-biofouling polymer coated magnetic iron oxide nanoparticles.

[1]  A. Zeng,et al.  Process‐induced cell cycle oscillations in CHO cultures: Online monitoring and model‐based investigation , 2019, Biotechnology and bioengineering.

[2]  HighWire Press,et al.  Molecular cancer therapeutics , 2016 .

[3]  M. Lidonnici,et al.  The second transferrin receptor regulates red blood cell production in mice. , 2015, Blood.

[4]  S. Sleijfer,et al.  Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy , 2014, Molecular Cancer Therapeutics.

[5]  Mostafa Ghannad-Rezaie,et al.  A radial flow microfluidic device for ultra-high-throughput affinity-based isolation of circulating tumor cells. , 2014, Small.

[6]  Robert B Livingston,et al.  Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges , 2014, Expert opinion on drug delivery.

[8]  I. Thompson,et al.  Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Kazunori Hoshino,et al.  Multiscale immunomagnetic enrichment of circulating tumor cells: from tubes to microchips. , 2014, Lab on a chip.

[10]  R. Weissleder,et al.  Imaging macrophages with nanoparticles. , 2014, Nature materials.

[11]  Jianjun Cheng,et al.  Protein corona significantly reduces active targeting yield. , 2013, Chemical communications.

[12]  Kazunori Hoshino,et al.  Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system , 2012, Biomedical Microdevices.

[13]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[14]  Albert J R Heck,et al.  Trends in ultrasensitive proteomics. , 2012, Current opinion in chemical biology.

[15]  Hengyi Xu,et al.  Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood. , 2011, Biomaterials.

[16]  M. Li,et al.  Carboxymethylated dextran-coated magnetic iron oxide nanoparticles for regenerable bioseparation. , 2011, Journal of nanoscience and nanotechnology.

[17]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[18]  Maciej Zborowski,et al.  Rare cell separation and analysis by magnetic sorting. , 2011, Analytical chemistry.

[19]  S. Farag,et al.  Quantification of non‐specific binding of magnetic micro‐ and nanoparticles using cell tracking velocimetry: Implication for magnetic cell separation and detection , 2010, Biotechnology and bioengineering.

[20]  T. Matsuura,et al.  Surface modifications for antifouling membranes. , 2010, Chemical reviews.

[21]  C. Punt,et al.  Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  J. Chalmers,et al.  Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells , 2009, Biotechnology and bioengineering.

[23]  Mieke Schutte,et al.  Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells , 2009, Journal of the National Cancer Institute.

[24]  John F. McDonald,et al.  Magnetic nanoparticle-peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells. , 2008, Journal of the American Chemical Society.

[25]  Luca Laurenti,et al.  The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. , 2008, Blood.

[26]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[27]  C Hollmann,et al.  DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD , 2005, Critical reviews in clinical laboratory sciences.

[28]  P. Chiusolo,et al.  Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. , 2004, Blood.

[29]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[30]  A. Seifalian,et al.  Magnetic beads (Dynabead™) toxicity to endothelial cells at high bead concentration: Implication for tissue engineering of vascular prosthesis , 2003, Cell Biology and Toxicology.

[31]  E. Wood.  The Lancet Oncology , 2003 .

[32]  T. Byrd,et al.  Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. , 1993, The Journal of clinical investigation.

[33]  G. Williams.  Cell biology and toxicology , 1990, Cell Biology and Toxicology.

[34]  A C Dornhorst,et al.  Review of Medical Physiology. , 1966 .

[35]  Shashi K Murthy,et al.  Fundamentals and application of magnetic particles in cell isolation and enrichment: a review , 2015, Reports on progress in physics. Physical Society.

[36]  H. Tran,et al.  Critical Reviews in Clinical Laboratory Sciences , 2012 .

[37]  D. Dearnaley,et al.  Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.